Skip to main content

Table 2 The relationship of changes in diaphragm and intercostal muscle thickness with patient characteristics, medications, and ventilator mode

From: Change in diaphragm and intercostal muscle thickness in mechanically ventilated patients: a prospective observational ultrasonography study

Variables

Change in diaphragm thickness

Change in intercostal muscle thickness

Decreased thickness (n = 50)

Unchanged (n = 15)

Increased thickness (n = 15)

p value

Decreased thickness (n = 48)

Unchanged (n = 17)

Increased thickness (n = 15)

p value

Age, mean ± SD, year

69 ± 2

69 ± 3

61 ± 3

0.10

70 ± 2

64 ± 3

66 ± 3

0.32

Male/female

34/16

10/5

10/5

0.99

32/16

13/4

9/6

0.60

Body mass index, mean ± SD, kg/m2

23 ± 1

24 ± 1

24 ± 1

0.72

23 ± 1a

26 ± 1

24 ± 1

< 0.01

APACHE II score

23 (18–29)

22 (20–31)

26 (22–32)

0.62

25 (17–30)

22 (17–27)

26 (22–32)

0.35

SOFA, mean in the first 3 days

9 (6–12)

8 (4–9)

10 (5–14)

0.33

9 (5–12)

7 (5–9)

9 (6–14)

0.22

Sepsis (sepsis-3 criteria), n (%)

22 (44)

5 (33)

4 (27)

0.43

18 (38)

6 (35)

7 (47)

0.77

Surgical admissions, n (%)

19 (38)

3 (20)

6 (40)

0.40

18 (38)

3 (18)

7 (47)

0.19

Medications, n (%)

Catecholamine*

35 (70)

11 (73)

10 (67)

0.92

35 (73)

10 (59)

11 (73)

0.53

Neuromuscular blocking agents†

7 (14)

1 (7)

0 (0)

0.25

6 (13)

1 (6)

1 (7)

0.66

Steroids‡

18 (36)

5 (33)

2 (13)

0.25

18 (38)

3 (18)

4 (27)

0.29

Aminoglycoside

1 (2)

1 (7)

0 (0)

0.47

1 (2)

0 (0)

1 (7)

0.46

Opioid

44 (88)

13 (87)

11 (73)

0.37

42 (88)

16 (94)

10 (67)

0.07

Midazolam

18 (36)

7 (46)

7 (47)

0.64

20 (42)

7 (41)

5 (33)

0.84

Dexmedetomidine

24 (48)

6 (40)

4 (27)

0.33

23 (48)

4 (24)

7 (47)

0.20

Propofol

8 (16)

3 (20)

6 (40)

0.14

7 (15)

7 (41)

3 (20)

0.07

Ventilatory settings during first 3 days

Controlled (ACV)/partial assist (PSV)

47/3

14/1

14/1

0.96

46/2

15/2

14/1

0.76

Set inspiratory pressure above PEEP

12 (10–12)

10 (10–12)

12 (10–14)

0.28

12 (10–13)a

10 (10–12)

12 (10–14)a

0.02

PEEP, cmH2O

8 (6–10)

8 (6–10)

6 (6–8)

0.31

8 (6–10)

8 (7–11)

8 (6–8)

0.11

Tidal volume/PBW, mL/kg

8.2 (7.3–9.6)

8.6 (7.6–10.2)

7.8 (7.2–9.7)

0.52

8.2 (7.2–9.7)

8.0 (7.8–9.7)

8.1 (7.2–9.7)

0.90

  1. Data were expressed as median (IQR) unless otherwise indicated. p values were obtained using one-way analysis of variance (ANOVA) or the Kruskal-Wallis test
  2. SD standard deviation, APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ Failure Assessment, ACV assist-control ventilation, PSV pressure-support ventilation, PEEP positive end-expiratory pressure, PBW predicted body weight
  3. aSignificant at p < 0.05 vs. Unchanged by post hoc Dunnett’s or Steel’s test
  4. *Catecholamine (dopamine, dobutamine, noradrenaline, or adrenaline)
  5. †Neuromuscular blockers with continuous use
  6. ‡Corticosteroids with intravenous or peroral use